Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma (Q43726973)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

phase III clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

Athanasios Dimopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Edward A. Stadtmauer

6

object named as

E A Stadtmauer

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

C Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

A Spencer

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

R Niesvizky

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

M Attal

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

M T Petrucci

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Z Yu

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

M Olesnyckyj

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

J B Zeldis

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

R D Knight

11

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

D M Weber

12

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

23 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

2147-2152

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Towards a new age in the treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Review of 1027 patients with newly diagnosed multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Improved survival in multiple myeloma and the impact of novel therapies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Lenalidomide in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

The evolving role of lenalidomide in the treatment of hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Lenalidomide in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.147

21 January 2018

Identifiers

10.1038/LEU.2009.147

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dimensions Publication ID

0 references

release_6sdsffsdabg5jds365w4pmhoom

1 reference

https://api.fatcat.wiki/v0/release/6sdsffsdabg5jds365w4pmhoom

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43726973&oldid=2206226156"